Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer

SIMPLE SUMMARY: Breast cancer (BC) is the most common malignant neoplasm in women and one of the leading causes of cancer death in women worldwide. Programmed death-ligand 1 (PD-L1) is becoming an emerging biomarker in BC in recent years. It has been correlated with worse outcomes in patients with h...

Descripción completa

Detalles Bibliográficos
Autores principales: Núñez Abad, Martín, Calabuig-Fariñas, Silvia, Lobo de Mena, Miriam, Torres-Martínez, Susana, García González, Clara, García García, José Ángel, Iranzo González-Cruz, Vega, Camps Herrero, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773553/
https://www.ncbi.nlm.nih.gov/pubmed/35053471
http://dx.doi.org/10.3390/cancers14020307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773553/
https://www.ncbi.nlm.nih.gov/pubmed/35053471
http://dx.doi.org/10.3390/cancers14020307

Ejemplares similares